A Three Part Study of MGV354 in Ocular Hypertension or Glaucoma
Status:
Completed
Trial end date:
2016-09-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the clinical profile of topical-ocular MGV354
merits further development for the indication of lowering intraocular pressure (IOP).